Shih-Chieh Shao, PhD candidate

Pharmacist
Keelung Chang Gung Memorial Hospital, Taiwan (Republic of China)

Poster(s):

• (74) A Real-World Effectiveness of Second-Line Osimertinib in NSCLC Patients: A Multi-Institutions Study in Taiwan
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (L) Comparative Cardiovascular Events Associated with Denosumab Vs. Zoledronate in The Elderly: A 5-Year Follow-Up Propensity Score Matching Cohort
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (Q) Effect Modification by Indications to The Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment – a Population-Based Retrospective Cohort Study
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (285) Associations of Thiazide Use with Skin Cancers: A Systematic Review and Meta-Analysis
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (316) Risk of Retinal Vein Occlusion in Colorectal Cancer Patients Using Anti-Vascular Endothelial Growth Factor: A Population-Based Cohort Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (144) Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan's Claim Data
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST